JAK-STAT signaling as an ARDS therapeutic target: Status and future trends
- 14 December 2022
- journal article
- review article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 208, 115382
Abstract
No abstract availableKeywords
All Related Versions
Funding Information
- Zhejiang Province Natural Science Foundation
This publication has 104 references indexed in Scilit:
- Role of Chemokines in the Pathogenesis of Acute Lung InjuryAmerican Journal of Respiratory Cell and Molecular Biology, 2012
- JAK and STAT Signaling Molecules in Immunoregulation and Immune-Mediated DiseaseImmunity, 2012
- Cytokine-dependent and cytokine-independent roles for Mcl-1: genetic evidence for multiple mechanisms by which Mcl-1 promotes survival in primary T lymphocytesCell Death & Disease, 2011
- Neutrophil transmigration triggers repair of the lung epithelium via β-catenin signalingProceedings of the National Academy of Sciences, 2011
- FoxM1 mediates the progenitor function of type II epithelial cells in repairing alveolar injury induced by Pseudomonas aeruginosaJournal of Experimental Medicine, 2011
- Janus kinases in immune cell signalingImmunological Reviews, 2009
- Canonical and non-canonical JAK–STAT signalingTrends in Cell Biology, 2008
- Cytokine Signaling Modules in Inflammatory ResponsesImmunity, 2008
- CD4+CD25+Foxp3+regulatory T cells induce alternative activation of human monocytes/macrophagesProceedings of the National Academy of Sciences, 2007
- Concomitant Activation of the JAK/STAT, PI3K/AKT, and ERK Signaling Is Involved in Leptin-Mediated Promotion of Invasion and Migration of Hepatocellular Carcinoma CellsCancer Research, 2007